Dolutegravir 50 mg & Lamivudine 300 mg Tablets are a fixed-dose antiretroviral combination used for the treatment of HIV-1 infection. The formulation combines Dolutegravir, an integrase inhibitor, and Lamivudine, an NRTI, to deliver effective viral suppression with once-daily dosing. Kureasia Pharma offers third-party and contract manufacturing services for this product in its WHO-... https://kureasiapharma.com/neurology-medicines-export-from-india-to-nigeria/